MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon

Jitender Monga(Henry Ford Health System), J. J. Ghosh(Henry Ford Health System)

Frontiers in Oncology

April 30, 2024

10.3389/fonc.2024.1387535

Cited by 0

Related Papers

MK591, a Second Generation Leukotriene Biosynthesis Inhibitor, Prevents Invasion and Induces Apoptosis in the Bone-Invading C4-2B Human Prostate Cancer Cells: Implications for the Treatment of Castration-Resistant, Bone-Metastatic Prostate Cancer

|PLoS ONE|2015|10

Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells

|Molecular Cancer Therapeutics|2023|6